ABSTRACT
INTRODUCTION
Smoking has been practiced in one form or the other since ancient times, dating back to 6000 BC where tobacco was first grown in America. Coronary artery disease and cerebro vascular disease are the leading causes of morta lity and morbidity in most parts of the world including India.
1
Atherosclerosis is the major lesion leading to these diseases. 2 Cigarette smoking is a wellestablished risk factor for atherogenesis and its sequalae-coronary artery disease, cerebrovascular disease and peripheral vascular disease.
3 According to the lipid hypothesis, the oxidized LDL-C plays a key role in atherogenesis. High level of serum cholesterol have been found to be associated with increased mortality due to vascular diseases. 4 High level of LDL-C and triglycerides are strongly associated with the occurrence of coronary artery disease while low level of HDL-C remains a significant independent predictor of coronary artery disease at any level of LDL-C
57

MATERIALS AND METHODS
A cross-sectional study was carried out at MGM Medical College and Hospital, Navi Mumbai, Maharashtra, India, over a period of one and half year, after receiving appro val from the Institutional Ethics Review Committee (IERC). Fifty smoker and 50 nonsmoker males in the age group of 20 to 30 years were enrolled.
The exclusion criteria included subjects with familial dyslipidemic disorders; subjects taking drugs affecting serum lipid level and subjects having disease or disorder affecting serum lipid levels, like diabetes mellitus, hypertension, hypo or hyperthyroidism, alcoholism, tuber culosis.
All smokers were classified on the basis of pack years as having smoked for: < 1 pack year; 1 to 2 pack years and > 2 pack years.
A pack year was taken as a history of smoking a pack containing 20 cigarettes or equivalent per day for 1 year.
A detailed history was elicited followed by clinical examination. All patients were examined carefully for evidence of dyslipidemia. Routine baseline investigations were done in all cases. Instructions were given to subjects to take a normal diet before lipid profile estimation was done. Venous blood from the antecubital vein was drawn 8 to 10 hours after fasting. A complete lipid profile was carried out which included total cholesterol, serum triglycerides, HDL, LDL levels.
RESULTS
The present study was undertaken with the aim of provi ding a quantitative estimation of the lipid profile in smokers and nonsmokers and comparing the obtained data with literature already published (Fig. 1) . In our study, we analyzed the extent to which the collected data supports the relationship between cigarette smoking and altered serum lipid profile in smokers.
The total cholesterol was estimated using the CHOD-PAP method. The mean serum cholesterol for smokers was 189 ± 19.88 mg/dl. In the control group, the mean total cholesterol was 159.24 ± 23.221 mg/dl. The mean LDL-C levels for smokers were 121.14 ± 18.212 mg/dl as compared to the control group with mean levels of 93.28 ± 23.726 mg/dl. The mean HDL-C for smokers in the present study was 38.02 ± 4.515 mg/dl. In the control group, the mean HDL-C was 42.56 ± 3.25 mg/dl. All the findings were found to be statistically significant.
The severity of smoking was assessed according to pack years. The smokers were divided into three groups: < 1 pack year; 1 to 2 pack years and > 2 pack years.
There was a linear increase in the values of total cholesterol, triglycerides and LDL-C as one progressed through the three groups suggesting a dose response rela tionship between severity of smoking and derangement in lipid levels which was statistically significant for total cholesterol and LDL-C. Similarly, HDL-C levels linearly decreased when progressing through pack years again suggesting a dose response relationship between severity of smoking and decrease in LDL-C levels ( Fig. 2 and Table 1 ).
DISCUSSION
Cigarette smoke contains more than 4000 different chemicals, which include components, like nicotine, tar, carbon monoxide, hydrogen cyanide well as various irritants. There have been a number of studies done on the relationship between cigarette smoking and its effects on lipids, mainly being international and a few Indian. The illeffects caused by smoking are legion and documented prior. Various mechanisms leading to lipid alteration by smoking are: (a) nicotine stimulates sym pathetic adrenal system leading to increase secretion of catecholamines resulting in increased lipolysis and increased concentration of plasma-free fatty acids (FFA) which further result in increased secretion of hepatic FFAs and hepatic triglycerides along with VLDL-C in the blood stream, 12 (b) fall in estrogen levels occurs due to smoking which further leads to decreased HDL-C 13 and (c) presence of hyperinsulinemia in smokers leads to increased cholesterol, LDL-C, VLDL-C, and TG due to decreased activity of lipoprotein lipase. It is a proven fact that smokers have a higher risk of vascular disease including coronary heart disease and cerebrovascular disease than nonsmokers. There have been many explanations which have been put forward for this association including altered blood coagu lability, decreased fibrinolysis, impaired integrity of the endothelial wall and changes in blood lipids and lipoprotein concentrations. 15, 16 Also, cigarette smoke has been identi fied as a carcinogen with increased risk of cancer of oral, naso oropharynx, larynx, gastrointestinal malignancies, urogenital malignancies. It is responsible for 90% of chronic obstructive pulmonary diseases and is detrimental to maternal and infant health.
CONCLUSION
Smoking of tobacco is a vice, which is harmful not only to the person who smokes but also to the innocent bystander who unfortunately happens to share the same air as the smoker. There has been a growing interest in the effects of smoking on the lipid profile as it has become clear that dyslipidemia is a major risk factor for atherosclerosis and vascular disease. It is a proven fact that smokers have a higher risk of vascular disease including coronary heart disease and cerebrovascular disease than nonsmokers due to an adverse lipid profile in these patients.
A NOTE ON CIGARETTE CESSATION
Smoking is the foremost preventable cause of death.
Smoking cessation is a dynamic cyclic process that leads to overcoming addictive behavior. A combination of counseling and pharmacological therapy when neces sary to help quit smoking, including nicotine gum, patch, bupropion, varenicline, etc.
